156 related articles for article (PubMed ID: 32318857)
21. Influence of body mass index on oncological outcomes in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Liu JY; Li YH; Liu ZW; Zhang ZL; Ye YL; Yao K; Jiang LJ; Han H; Qin ZK; Zhou FJ
Int J Urol; 2014 Feb; 21(2):136-42. PubMed ID: 23931096
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Lim JH; Jeong IG; Park JY; You D; Hong B; Hong JH; Ahn H; Kim CS
Korean J Urol; 2015 Jul; 56(7):498-504. PubMed ID: 26175868
[TBL] [Abstract][Full Text] [Related]
24. Prognostic score predicts overall survival following complete urinary tract extirpation.
Akand M; Muilwijk T; Van Der Aa F; Gevaert T; Milenkovic U; Moris L; Blyweert W; Van Poppel H; Albersen M; Joniau S
Scand J Urol; 2020 Feb; 54(1):70-79. PubMed ID: 31975650
[No Abstract] [Full Text] [Related]
25. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK
Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890
[TBL] [Abstract][Full Text] [Related]
26. Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma.
Abdul-Muhsin H; De Lucia N; Singh V; Faraj K; Rose K; Cha S; Zhang N; Judge N; Navaratnam A; Tyson M; Ho T; Jacobsohn K; Castle E
Urol Oncol; 2021 Feb; 39(2):133.e9-133.e16. PubMed ID: 33069555
[TBL] [Abstract][Full Text] [Related]
27. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
[TBL] [Abstract][Full Text] [Related]
28. Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
Matsumoto K; Novara G; Gupta A; Margulis V; Walton TJ; Roscigno M; Ng C; Kikuchi E; Zigeuner R; Kassouf W; Fritsche HM; Ficarra V; Martignoni G; Tritschler S; Rodriguez JC; Seitz C; Weizer A; Remzi M; Raman JD; Bolenz C; Bensalah K; Koppie TM; Karakiewicz PI; Wood CG; Montorsi F; Iwamura M; Shariat SF
BJU Int; 2011 Oct; 108(8 Pt 2):E304-9. PubMed ID: 21507184
[TBL] [Abstract][Full Text] [Related]
29. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
30. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
31. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S
Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271
[TBL] [Abstract][Full Text] [Related]
32. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.
Favaretto RL; Shariat SF; Chade DC; Godoy G; Adamy A; Kaag M; Bochner BH; Coleman J; Dalbagni G
Eur Urol; 2010 Oct; 58(4):574-80. PubMed ID: 20637540
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management.
Pelcovits A; Mueller-Leonhard C; Mega A; Amin A; Kim SP; Golijanin D; Gershman B
World J Urol; 2020 May; 38(5):1243-1252. PubMed ID: 31388818
[TBL] [Abstract][Full Text] [Related]
34. Is bladder preservation safe? The oncology outcomes of patients after 2-sided radical nephroureterectomies due to bilateral upper urinary tract urothelial carcinomas.
Kao YL; Yang WH; Ou CH
Int Urol Nephrol; 2022 Jan; 54(1):63-69. PubMed ID: 34783981
[TBL] [Abstract][Full Text] [Related]
35. The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.
Nison L; Rouprêt M; Bozzini G; Ouzzane A; Audenet F; Pignot G; Ruffion A; Cornu JN; Hurel S; Valeri A; Roumiguie M; Polguer T; Hoarau N; Mérigot de Treigny O; Xylinas E; Matte A; Droupy S; Fais PO; Descazeaud A; Colin P;
World J Urol; 2013 Feb; 31(1):69-76. PubMed ID: 23070533
[TBL] [Abstract][Full Text] [Related]
36. Impact of statin use on oncologic outcomes of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Xylinas E; Kluth LA; Crivelli JJ; Rieken M; Margulis V; Seitz C; Shariat SF
Eur Urol; 2013 Jun; 63(6):1134-5. PubMed ID: 23540954
[No Abstract] [Full Text] [Related]
37. The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy.
Tang Q; Xiong G; Li X; Fang D; Xi C; Zhang L; Yang K; Yao L; Zhang C; Yu W; He Q; Gong K; He Z; Zhou L
World J Urol; 2016 Jun; 34(6):871-7. PubMed ID: 26497969
[TBL] [Abstract][Full Text] [Related]
38. Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis.
Cirulli GO; Corsi N; Rakic I; Stephens A; Chiarelli G; Finati M; Davis M; Tinsley S; Sood A; Buffi N; Lughezzani G; Carrieri G; Salonia A; Briganti A; Montorsi F; Rogers C; Abdollah F
BJU Int; 2024 May; 133(5):555-563. PubMed ID: 38097533
[TBL] [Abstract][Full Text] [Related]
39. Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Shirotake S; Hayakawa N; Kosaka T; Miyajima A; Momma T; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
BJU Int; 2013 Jul; 112(2):E28-34. PubMed ID: 23795795
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis.
Mori K; Janisch F; Mostafaei H; Lysenko I; Kimura S; Egawa S; Shariat SF
Urol Oncol; 2020 May; 38(5):315-333. PubMed ID: 32088103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
